Astragaloside IV regulates insulin resistance and inflammatory response of adipocytes via modulating miR-21/PTEN/PI3K/AKT signaling

Background The progression of Type 2 Diabetes Mellitus (T2DM) can lead to various complications. Compounds derived from natural products have been found to be effective in combatting T2DM. This study aimed to investigate the effects of Astragaloside IV (AS-IV) on insulin resistance and the inflammat...

Full description

Saved in:
Bibliographic Details
Published inEndocrine, metabolic & immune disorders drug targets
Main Authors Guo, Xuxi, Yin, Taoqing, Chen, Dongni, Xu, Shuai, Ye, Renqun, Zhang, Yue
Format Journal Article
LanguageEnglish
Published United Arab Emirates 01.01.2023
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Background The progression of Type 2 Diabetes Mellitus (T2DM) can lead to various complications. Compounds derived from natural products have been found to be effective in combatting T2DM. This study aimed to investigate the effects of Astragaloside IV (AS-IV) on insulin resistance and the inflammatory response of adipocytes. The study also aimed to determine the downstream signaling pathways involved. Materials and methods The glucose consumption of adipocytes was assessed using a glucose assay kit. qRT-PCR, Western blot, and ELISA assays were used to measure mRNA and protein levels. The interaction between miR-21 and PTEN was assessed using a Dual-luciferase reporter assay. Results The results showed that AS-IV increased glucose consumption and the expression of GLUT-4 in adipocytes with insulin resistance in a concentration-dependent manner. However, AS-IV decreased the protein levels of TNF-α and IL-6 in these cells. Additionally, AS-IV up-regulated miR-21 expression in adipocytes with insulin resistance in a concentration-dependent manner. Furthermore, miR-21 overexpression increased glucose consumption and GLUT-4 expression but decreased TNF-α and IL-6 protein levels in adipocytes. Conversely, miR-21 inhibition attenuated the AS-IV-induced increase in glucose consumption and GLUT-4 expression and the decrease in TNF-α and IL-6 protein levels in adipocytes. MiR-21 also inversely regulated PTEN in adipocytes, and PTEN overexpression had effects similar to miR-21 inhibition in AS-IV-treated adipocytes. Finally, AS-IV up-regulated p-PI3K and p-AKT protein expression in adipocytes, which was attenuated by miR-21 inhibition. Conclusion The study concluded that AS-IV attenuated insulin resistance and the inflammatory response in adipocytes. The mechanistic studies indicated that AS-IV modulated the miR-21/PTEN/PI3K/AKT signaling in adipocytes to exert these effects.
AbstractList Background The progression of Type 2 Diabetes Mellitus (T2DM) can lead to various complications. Compounds derived from natural products have been found to be effective in combatting T2DM. This study aimed to investigate the effects of Astragaloside IV (AS-IV) on insulin resistance and the inflammatory response of adipocytes. The study also aimed to determine the downstream signaling pathways involved. Materials and methods The glucose consumption of adipocytes was assessed using a glucose assay kit. qRT-PCR, Western blot, and ELISA assays were used to measure mRNA and protein levels. The interaction between miR-21 and PTEN was assessed using a Dual-luciferase reporter assay. Results The results showed that AS-IV increased glucose consumption and the expression of GLUT-4 in adipocytes with insulin resistance in a concentration-dependent manner. However, AS-IV decreased the protein levels of TNF-α and IL-6 in these cells. Additionally, AS-IV up-regulated miR-21 expression in adipocytes with insulin resistance in a concentration-dependent manner. Furthermore, miR-21 overexpression increased glucose consumption and GLUT-4 expression but decreased TNF-α and IL-6 protein levels in adipocytes. Conversely, miR-21 inhibition attenuated the AS-IV-induced increase in glucose consumption and GLUT-4 expression and the decrease in TNF-α and IL-6 protein levels in adipocytes. MiR-21 also inversely regulated PTEN in adipocytes, and PTEN overexpression had effects similar to miR-21 inhibition in AS-IV-treated adipocytes. Finally, AS-IV up-regulated p-PI3K and p-AKT protein expression in adipocytes, which was attenuated by miR-21 inhibition. Conclusion The study concluded that AS-IV attenuated insulin resistance and the inflammatory response in adipocytes. The mechanistic studies indicated that AS-IV modulated the miR-21/PTEN/PI3K/AKT signaling in adipocytes to exert these effects.
Author Yin, Taoqing
Xu, Shuai
Guo, Xuxi
Zhang, Yue
Ye, Renqun
Chen, Dongni
Author_xml – sequence: 1
  givenname: Xuxi
  surname: Guo
  fullname: Guo, Xuxi
  organization: Department of Endocrinology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, the Affiliated Hospital of Guangzhou University of Chinese Medicine, Shenzhen, China
– sequence: 2
  givenname: Taoqing
  surname: Yin
  fullname: Yin, Taoqing
  organization: Department of Endocrinology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, the Affiliated Hospital of Guangzhou University of Chinese Medicine, Shenzhen, China
– sequence: 3
  givenname: Dongni
  surname: Chen
  fullname: Chen, Dongni
  organization: Department of Endocrinology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, the Affiliated Hospital of Guangzhou University of Chinese Medicine, Shenzhen, China
– sequence: 4
  givenname: Shuai
  surname: Xu
  fullname: Xu, Shuai
  organization: Department of Endocrinology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, the Affiliated Hospital of Guangzhou University of Chinese Medicine, Shenzhen, China
– sequence: 5
  givenname: Renqun
  surname: Ye
  fullname: Ye, Renqun
  organization: Shenzhen Bao'an Traditional Chinese Medicine Hospital Department of Endocrinology Shenzhen China
– sequence: 6
  givenname: Yue
  surname: Zhang
  fullname: Zhang, Yue
  organization: Department of Endocrinology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, the Affiliated Hospital of Guangzhou University of Chinese Medicine, Shenzhen, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37366351$$D View this record in MEDLINE/PubMed
BookMark eNo1kNFKwzAYhYMobs69gsQHqE3yt016OcacY0OHTG_H3yQtgTYtTSfs2he3Q706cA7ng3PuyLVvvSXkkbMnwWUScyV5CgwEZFkmgGVC8jFg7IpMheAiAiVhQuYhuIKlACoHkLdkAnIsQMqn5HsRhh4rrNvgjKWbT9rb6lTjYAN1Ppxq50cnuDCg15aiN6Nd1tg0OLT9-ZJ1rQ-WtiVF47pWny_VL4e0ac0F5HxFG_ceCR7vD6vXeL-BbbzYHmhwlceRX92TmxLrYOd_OiMfz6vD8iXava03y8UuKhIphkhrJbFMBC8yHBdLIxSDMtFK51KCKmWRW840gzxB5AY1z23KMqUSmZXWGjEjD7_c7lQ01hy73jXYn4__b4gfvklljw
CitedBy_id crossref_primary_10_1016_j_heliyon_2024_e35747
crossref_primary_10_3390_metabo14020122
crossref_primary_10_1016_j_prp_2024_155091
crossref_primary_10_3892_br_2024_1918
crossref_primary_10_3390_molecules28166118
crossref_primary_10_1016_j_brainres_2025_149451
ContentType Journal Article
Copyright Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Copyright_xml – notice: Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
DBID NPM
DOI 10.2174/1871530323666230627121700
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 2212-3873
ExternalDocumentID 37366351
Genre Journal Article
GroupedDBID ABJNI
ALMA_UNASSIGNED_HOLDINGS
NPM
ID FETCH-LOGICAL-b472t-cc87af421b6a3237d2803f4c8c97738f7b9e10c0394aa1dac19e50688476feed2
IngestDate Thu Jan 02 22:52:21 EST 2025
IsPeerReviewed true
IsScholarly true
Keywords T2DM
AS-IV
miR-21
inflammation
adipocytes
insulin resistance
Language English
License Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-b472t-cc87af421b6a3237d2803f4c8c97738f7b9e10c0394aa1dac19e50688476feed2
PMID 37366351
ParticipantIDs pubmed_primary_37366351
PublicationCentury 2000
PublicationDate 2023-01-01
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-01-01
  day: 01
PublicationDecade 2020
PublicationPlace United Arab Emirates
PublicationPlace_xml – name: United Arab Emirates
PublicationTitle Endocrine, metabolic & immune disorders drug targets
PublicationTitleAlternate Endocr Metab Immune Disord Drug Targets
PublicationYear 2023
SSID ssib053389337
Score 2.353132
Snippet Background The progression of Type 2 Diabetes Mellitus (T2DM) can lead to various complications. Compounds derived from natural products have been found to be...
SourceID pubmed
SourceType Index Database
Title Astragaloside IV regulates insulin resistance and inflammatory response of adipocytes via modulating miR-21/PTEN/PI3K/AKT signaling
URI https://www.ncbi.nlm.nih.gov/pubmed/37366351
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6lRap6QSDeLy0SN8sk3rW99rFChZaKCiEX5Vat17vBErFDiBHttb-Ef8rMrl9EVDwuTmTHz_kyO994dj5CXmgVxiZmxk-FVD6Mx8qXwYz7JtIJ11FeCKve8O40PjoL386j-WTyY1S11Gzyl-ryt_NK_seqsA7sirNk_8Gy_UFhBXwH-8ISLAzLv7LxAeYpwMXXqLnpAZFbO2V5W2TlasyBTWOE2M0LgLMCBJbu1fra1cdqVwtQrmp1gbt-KyUK5Fhdr2rhLcsPPkN_9z47PMWPY36CXRhOMg-LP-TnbvDr8vtVUat16TKlS70BlGEjbYRYiZNRNL4Ush0_v3rFull4rhi9j-3fNDZ7O2--l71Lco0OMll_6U5mKxJal1lXi6r_7byxCd1PjSzHGQ3GRxkNbT0fY9hJMXEaJ9s-HjkUphuA6UUw_jIOBAx5FBMBw2aD433AXKulNT4XHGOr4M9bt9pvd5t2yA4QEVRWHdJBECpDuMfFHnneXtj02svaJ3vdobYYjI1kslvkZktB6IHD020y0dUdcvULlujxR9pjibZYogOWKGCJjrFEOyzR2tABSxSwRAcsUYelKSJpijiaAopoj6K75Oz1YfbqyG8FOvw8FGzjK5UIaUIW5LGEOxYFSp2ZUCUKWAVPjMhTHczUjKehlEEhVZDqCFWOQhEbCM7YPbJb1ZV-QKhQSKbzPBK5DE0gElOERVIYkapAFdHsIbnvntn5ynVhOe-e5qNrtzwm-wO8npAbBv72-inEkJv8mbXjT3XTcJI
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Astragaloside+IV+regulates+insulin+resistance+and+inflammatory+response+of+adipocytes+via+modulating+miR-21%2FPTEN%2FPI3K%2FAKT+signaling&rft.jtitle=Endocrine%2C+metabolic+%26+immune+disorders+drug+targets&rft.au=Guo%2C+Xuxi&rft.au=Yin%2C+Taoqing&rft.au=Chen%2C+Dongni&rft.au=Xu%2C+Shuai&rft.date=2023-01-01&rft.eissn=2212-3873&rft_id=info:doi/10.2174%2F1871530323666230627121700&rft_id=info%3Apmid%2F37366351&rft_id=info%3Apmid%2F37366351&rft.externalDocID=37366351